Physician profile
Christopher M Putnam
NPI 1821068859
$1,461.50
in general payments reported to CMS, 2019-2025
11 companies · $505 in 2025
The $505 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $195 · 2023: $647 · 2024: $115 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667 · Consulting Fee: $400 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.83 |
| Consulting Fee | $400.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $321.64 | 2023-2025 | Clariti Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $200.00 | 2023-2025 | Air Optix |
| Johnson & Johnson Vision Care, INC. | $200.00 | 2023-2025 | Acuvue |
| Glaukos Corporation | $162.81 | 2022 | |
| Abbvie INC. | $125.00 | 2023 | |
| Sun Pharmaceutical Industries INC. | $115.45 | 2024 | |
| Bausch & Lomb Americas INC. | $99.92 | 2023 | Vyzulta |
| Lkc Technologies, INC. | $96.59 | 2025 | |
| Apellis Pharmaceuticals, INC. | $66.04 | 2025 | Syfovre |
| Ani Pharmaceuticals, INC. | $42.19 | 2025 | Purified Cortrophin Gel |
| Oyster Point Pharma, INC. | $31.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Putnam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.